These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22017504)

  • 1. Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum.
    San Sebastian W; Richardson RM; Kells AP; Lamarre C; Bringas J; Pivirotto P; Salegio EA; Dearmond SJ; Forsayeth J; Bankiewicz KS
    Hum Gene Ther; 2012 Feb; 23(2):210-7. PubMed ID: 22017504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.
    Ciesielska A; Samaranch L; San Sebastian W; Dickson DW; Goldman S; Forsayeth J; Bankiewicz KS
    PLoS One; 2017; 12(2):e0169965. PubMed ID: 28166239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats.
    Ciesielska A; Sharma N; Beyer J; Forsayeth J; Bankiewicz K
    PLoS One; 2015; 10(4):e0122708. PubMed ID: 25860990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach.
    Bankiewicz KS; Eberling JL; Kohutnicka M; Jagust W; Pivirotto P; Bringas J; Cunningham J; Budinger TF; Harvey-White J
    Exp Neurol; 2000 Jul; 164(1):2-14. PubMed ID: 10877910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parameters.
    Sanftner LM; Sommer JM; Suzuki BM; Smith PH; Vijay S; Vargas JA; Forsayeth JR; Cunningham J; Bankiewicz KS; Kao H; Bernal J; Pierce GF; Johnson KW
    Exp Neurol; 2005 Aug; 194(2):476-83. PubMed ID: 16022872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain.
    Cunningham J; Pivirotto P; Bringas J; Suzuki B; Vijay S; Sanftner L; Kitamura M; Chan C; Bankiewicz KS
    Mol Ther; 2008 Jul; 16(7):1267-75. PubMed ID: 18523450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain.
    Hadaczek P; Kohutnicka M; Krauze MT; Bringas J; Pivirotto P; Cunningham J; Bankiewicz K
    Hum Gene Ther; 2006 Mar; 17(3):291-302. PubMed ID: 16544978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus-mediated gene transfer of human aromatic L-amino acid decarboxylase protects mixed striatal primary cultures from L-DOPA toxicity.
    Doroudchi MM; Liauw J; Heaton K; Zhen Z; Forsayeth JR
    J Neurochem; 2005 May; 93(3):634-40. PubMed ID: 15836622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAFETY AND TOLERABILITY OF MRI-GUIDED INFUSION OF AAV2-hAADC INTO THE MID-BRAIN OF NON-HUMAN PRIMATE.
    San Sebastian W; Kells AP; Bringas J; Samaranch L; Hadaczek P; Ciesielska A; Macayan M; Pivirotto PJ; Forsayeth J; Osborne S; Wright JF; Green F; Heller G; Bankiewicz KS
    Mol Ther Methods Clin Dev; 2014 Oct; 3():14049-. PubMed ID: 25541617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC.
    Hadaczek P; Eberling JL; Pivirotto P; Bringas J; Forsayeth J; Bankiewicz KS
    Mol Ther; 2010 Aug; 18(8):1458-61. PubMed ID: 20531394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons.
    Pearson TS; Gupta N; San Sebastian W; Imamura-Ching J; Viehoever A; Grijalvo-Perez A; Fay AJ; Seth N; Lundy SM; Seo Y; Pampaloni M; Hyland K; Smith E; de Oliveira Barbosa G; Heathcock JC; Minnema A; Lonser R; Elder JB; Leonard J; Larson P; Bankiewicz KS
    Nat Commun; 2021 Jul; 12(1):4251. PubMed ID: 34253733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant effects of convection-enhanced delivery of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys.
    Johnston LC; Eberling J; Pivirotto P; Hadaczek P; Federoff HJ; Forsayeth J; Bankiewicz KS
    Hum Gene Ther; 2009 May; 20(5):497-510. PubMed ID: 19203243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of AAV2-hAADC-transduced cells after 3 years in Parkinsonian monkeys.
    Daadi MM; Pivirotto P; Bringas J; Cunningham J; Forsayeth J; Eberling J; Bankiewicz KS
    Neuroreport; 2006 Feb; 17(2):201-4. PubMed ID: 16407771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The localization and functional contribution of striatal aromatic L-amino acid decarboxylase to L-3,4-dihydroxyphenylalanine decarboxylation in rodent parkinsonian models.
    Nakamura K; Ahmed M; Barr E; Leiden JM; Kang UJ
    Cell Transplant; 2000; 9(5):567-76. PubMed ID: 11144954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time MR imaging of adeno-associated viral vector delivery to the primate brain.
    Fiandaca MS; Varenika V; Eberling J; McKnight T; Bringas J; Pivirotto P; Beyer J; Hadaczek P; Bowers W; Park J; Federoff H; Forsayeth J; Bankiewicz KS
    Neuroimage; 2009 Aug; 47 Suppl 2(Suppl 2):T27-35. PubMed ID: 19095069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys.
    Bankiewicz KS; Daadi M; Pivirotto P; Bringas J; Sanftner L; Cunningham J; Forsayeth JR; Eberling JL
    Exp Neurol; 2006 Feb; 197(2):363-72. PubMed ID: 16337943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease.
    Richardson RM; Kells AP; Rosenbluth KH; Salegio EA; Fiandaca MS; Larson PS; Starr PA; Martin AJ; Lonser RR; Federoff HJ; Forsayeth JR; Bankiewicz KS
    Mol Ther; 2011 Jun; 19(6):1048-57. PubMed ID: 21343917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeys.
    Forsayeth JR; Eberling JL; Sanftner LM; Zhen Z; Pivirotto P; Bringas J; Cunningham J; Bankiewicz KS
    Mol Ther; 2006 Oct; 14(4):571-7. PubMed ID: 16781894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T2 imaging in monitoring of intraparenchymal real-time convection-enhanced delivery.
    Richardson RM; Gimenez F; Salegio EA; Su X; Bringas J; Berger MS; Bankiewicz KS
    Neurosurgery; 2011 Jul; 69(1):154-63; discussion 163. PubMed ID: 21430597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease.
    Christine CW; Starr PA; Larson PS; Eberling JL; Jagust WJ; Hawkins RA; VanBrocklin HF; Wright JF; Bankiewicz KS; Aminoff MJ
    Neurology; 2009 Nov; 73(20):1662-9. PubMed ID: 19828868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.